Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Benefits and risks of preventative aspirin

Aspirin Foundation

Published: 7 Nov 2011

Views: 5272

Rating:

Save

Prof Jane Armitage - Clinical Trials Service Unit, Oxford University, UK

Prof Armitage talks to ecancer at the Aspirin Foundation 'Aspirin for the older person' meeting at the Royal Society of Medicine, London, 3rd November 2011. Prof Armitage discusses the risks of taking regular aspirin, such as gastrointestinal bleeding, versus the benefits it can bring to vascular disease and cancer. She discusses trials underway, such as aspirin vs placebo for various diseases, due to report 2017.

Categories:
Policy
Elderly

Related Videos

Pembrolizumab improves breast cancer outcomes regardless of age or menopausal...

Dr Javier Cortes - International Breast Cancer Center, Barcelona, Spain

Pembrolizumab improves breast cancer outcomes regardless of age or menopausal status ( Dr Javier Cortes - International Breast Cancer Center, Barcelona, Spain )

The Safari Concept

Dr Christian Ntizimira - Executive Director, ACREOL, Kigali, Rwanda

The Safari Concept ( Dr Christian Ntizimira - Executive Director, ACREOL, Kigali, Rwanda )

Innovative treatments for solid tumours – TTFields as a therapeutic modality

Dr Giuseppe Lombardi, Dr Helen Bulbeck, Prof Dean Fennell and Dr Tadeja Urbanic...

Innovative treatments for solid tumours – TTFields as a therapeutic modality ( Dr Giuseppe Lombardi, Dr Helen Bulbeck, Prof Dean Fennell and Dr Tadeja Urbanic-Purkart )

Population-based cancer registries in Nigeria and the National Cancer Control...

Dr Ismail Zubairu - Ahmadu Bello University Zaria, Zaria, Nigeria

Population-based cancer registries in Nigeria and the National Cancer Control Programme ( Dr Ismail Zubairu - Ahmadu Bello University Zaria, Zaria, Nigeria )

The enhancing oncology model and other value-based propositions

Dr Kelly King - Memorial Healthcare System, Florida, USA

The enhancing oncology model and other value-based propositions ( Dr Kelly King - Memorial Healthcare System, Florida, USA )

NSIA and BVGH aim to improve patient outcomes and access to quality cancer care

Dr Tolulope Adewole - Program Lead, MedServe, Nigeria Sovereign Investment...

NSIA and BVGH aim to improve patient outcomes and access to quality cancer care ( Dr Tolulope Adewole - Program Lead, MedServe, Nigeria Sovereign Investment Authority (NSIA) )

Choosing Wisely palliative care: life until the end in African context

Dr Christian Ntizimira - Executive Director, ACREOL

Choosing Wisely palliative care: life until the end in African context ( Dr Christian Ntizimira - Executive Director, ACREOL )

TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small...

Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany

TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany )

Durable effect of imatinib and metronomic chemotherapy with capecitabine in...

Dr Sana Al-Sukhun - Al Hyatt Oncology Practice, Amman, Jordan

Durable effect of imatinib and metronomic chemotherapy with capecitabine in pancreatic carcinoma ( Dr Sana Al-Sukhun - Al Hyatt Oncology Practice, Amman, Jordan )

More from ecancer